procarbazine

简明释义

英[/proʊˈkɑːr.bə.ziːn/]美[/proʊˈkɑːr.bə.ziːn/]

n. 甲基苄肼；甲苄肼（一种抗肿瘤药）

英英释义

单词用法

同义词

反义词

例句

1.Procarbazine, nitrogen mustard, and ifosfamide, which can increase risk for myelodysplastic syndromes and acute myelogenous leukemia.

丙卡巴肼、氮芥和异环磷酰胺：可增加患骨髓增生异常综合症和急性粒细胞白血病的风险。

2.Procarbazine, nitrogen mustard, and ifosfamide, which can increase risk for myelodysplastic syndromes and acute myelogenous leukemia.

丙卡巴肼、氮芥和异环磷酰胺：可增加患骨髓增生异常综合症和急性粒细胞白血病的风险。

3.Procarbazine may increase risk of this disease.

丙卡巴肼可能增加这种患病风险。

4.The doctor prescribed procarbazine to treat my Hodgkin's lymphoma.

医生开了丙氟氨酸来治疗我的霍奇金淋巴瘤。

5.Patients taking procarbazine should be monitored for potential side effects.

服用丙氟氨酸的患者应监测潜在的副作用。

6.Before starting procarbazine, the oncologist explained its mechanism of action.

在开始使用丙氟氨酸之前，肿瘤科医生解释了它的作用机制。

7.It's important to avoid certain foods while on procarbazine treatment.

在接受丙氟氨酸治疗期间，避免某些食物是很重要的。

8.The combination of procarbazine and other chemotherapy drugs can enhance treatment efficacy.

将丙氟氨酸与其他化疗药物结合使用可以增强治疗效果。

作文

Procarbazine is a chemotherapy medication that is primarily used in the treatment of certain types of cancer, particularly Hodgkin's lymphoma and other hematological malignancies. It belongs to a class of drugs known as alkylating agents, which work by interfering with the DNA replication process in cancer cells, ultimately leading to cell death. Understanding the role of procarbazine (普卡巴嗪) in cancer therapy is crucial for both patients and healthcare providers alike. The history of procarbazine (普卡巴嗪) dates back to the 1960s when it was first introduced as an effective treatment option for patients suffering from Hodgkin's disease. This type of cancer affects the lymphatic system, which is a crucial part of the body’s immune response. The introduction of procarbazine (普卡巴嗪) marked a significant advancement in the field of oncology, providing patients with a new line of defense against this formidable disease. One of the key mechanisms of action of procarbazine (普卡巴嗪) is its ability to form reactive intermediates that can bind to DNA, leading to cross-linking and subsequent disruption of the cancer cell's ability to divide and grow. This makes it particularly effective when used in combination with other chemotherapy agents, enhancing the overall treatment efficacy. Patients prescribed procarbazine (普卡巴嗪) typically receive it in pill form, making it convenient for outpatient therapy. However, like many chemotherapy drugs, procarbazine (普卡巴嗪) is not without its side effects. Common side effects include nausea, fatigue, and a decrease in white blood cell count, which can increase the risk of infections. It is essential for patients to discuss these potential side effects with their healthcare provider to ensure they are adequately monitored throughout treatment. In addition to its use in Hodgkin's lymphoma, procarbazine (普卡巴嗪) has also been explored for its efficacy in treating other cancers, such as non-Hodgkin lymphoma and brain tumors. Its versatility as a chemotherapeutic agent highlights the importance of ongoing research to discover the full potential of procarbazine (普卡巴嗪) in oncology. As with any medication, the decision to use procarbazine (普卡巴嗪) must be made based on a thorough evaluation of the patient's specific condition, overall health, and treatment goals. Oncologists often consider various factors, including the type and stage of cancer, previous treatments, and the patient's preferences, before recommending procarbazine (普卡巴嗪) as part of a comprehensive treatment plan. In conclusion, procarbazine (普卡巴嗪) represents a vital tool in the arsenal against cancer, particularly in the treatment of Hodgkin's lymphoma. Its unique mechanism of action, combined with its historical significance in cancer therapy, underscores the importance of understanding this medication. As research continues to evolve, it is hoped that procarbazine (普卡巴嗪) will remain a key player in the fight against cancer, providing hope and improved outcomes for patients around the world.

普卡巴嗪是一种化疗药物，主要用于治疗某些类型的癌症，特别是霍奇金淋巴瘤和其他血液恶性肿瘤。它属于一种称为烷化剂的药物类别，通过干扰癌细胞中的DNA复制过程来发挥作用，最终导致细胞死亡。了解普卡巴嗪在癌症治疗中的作用对患者和医疗提供者都至关重要。 普卡巴嗪的历史可以追溯到20世纪60年代，当时它首次被引入作为有效的治疗选择，以帮助患有霍奇金病的患者。这种类型的癌症影响淋巴系统，而淋巴系统是身体免疫反应的重要组成部分。普卡巴嗪的引入标志着肿瘤学领域的一项重大进展，为患者提供了一种新的抵御这种可怕疾病的防线。 普卡巴嗪的关键作用机制之一是它能够形成反应性中间体，这些中间体可以与DNA结合，导致交联并随后破坏癌细胞分裂和生长的能力。这使得它在与其他化疗药物联合使用时特别有效，增强了整体治疗效果。 被处方使用普卡巴嗪的患者通常以药丸形式服用，使其对于门诊治疗更加方便。然而，与许多化疗药物一样，普卡巴嗪并非没有副作用。常见副作用包括恶心、疲劳和白细胞计数下降，这可能增加感染的风险。患者必须与医疗提供者讨论这些潜在副作用，以确保在整个治疗过程中得到适当的监测。 除了用于霍奇金淋巴瘤外，普卡巴嗪还被研究用于治疗其他癌症，例如非霍奇金淋巴瘤和脑肿瘤。它作为一种化疗药物的多功能性突显了持续研究的重要性，以发现普卡巴嗪在肿瘤学中的全部潜力。 与任何药物一样，使用普卡巴嗪的决定必须基于对患者特定状况、整体健康状况和治疗目标的全面评估。肿瘤科医生通常会考虑各种因素，包括癌症的类型和阶段、以前的治疗以及患者的偏好，然后推荐将普卡巴嗪纳入综合治疗计划。 总之，普卡巴嗪代表了抗击癌症的重要工具，特别是在霍奇金淋巴瘤的治疗中。它独特的作用机制，加上在癌症治疗中的历史意义，突显了理解这种药物的重要性。随着研究的不断发展，希望普卡巴嗪能继续在抗击癌症中发挥关键作用，为世界各地的患者提供希望和改善的结果。